BPC-157 prevented catalepsy development when given before reserpine and reversed established catalepsy when administered 24 hours after vesicle depletion
Half of participants with obesity who received CagriSema reached a non-obese BMI by the end of treatment
"Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs"
Later, Lee and I both attended a talk on peptides by Steven A
Before the transition to human investigation can take place, multiple layers of scientific, safety, quality and regulatory evidence must be generated and reviewed
Meis, ar Ergin, and Sybren de Hoog One Health Mycology 1: 4-13 (2023)